Predicting poor response to anti-osteoporosis therapy: a machine learning model integrating clinical and novel biomarker data - Top-Institutions - MDSpire

Predicting poor response to anti-osteoporosis therapy: a machine learning model integrating clinical and novel biomarker data

  • By

  • Yannan Bi

  • Maolin Zhang

  • Weiqiong Zhang

  • Jiahong Li

  • May 14, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Third Affiliated Hospital, Guangzhou Medical University
    Third Affiliated Hospital, Guangzhou Medical University

    Guangzhou, Guangdong

    Key Differentiators

    • Endocrinology

  • #2

    Fifth Affiliated Hospital, Guangzhou Medical University
    Fifth Affiliated Hospital, Guangzhou Medical University

    Guangzhou, Guangdong

    Key Differentiators

    • Endocrinology

  • #3

    Hospital Clínico of Valencia
    Hospital Clínico of Valencia

    Valencia, Valencia

    Key Differentiators

    • Endocrinology

  • #4

    European Society for Blood and Marrow Transplantation (EBMT)
    European Society for Blood and Marrow Transplantation (EBMT)

    N/A, N/A

    Key Differentiators

    • Endocrinology

  • #5

    EBMT registry
    EBMT registry

    N/A, N/A

    Key Differentiators

    • Endocrinology

Original Source(s)

Predicting poor response to anti-osteoporosis therapy: a machine learning model integrating clinical and novel biomarker data

  • by Yannan Bi, Maolin Zhang, Weiqiong Zhang, Jiahong Li

  • May 14, 2026

Related Content

Is muscle strength an overlooked parameter in patients affected by mild autonomous cortisol secretion?

Osteoporotic fractures prediction in Chinese postmenopausal women: a machine learning-based multi-dimensional approach

MAFLD is associated with lower bone mineral density in patients with type 2 diabetes: an exploratory cross-sectional analysis of a potential indirect association with HOMA-IR